PSM Statement on the New Pilot Program from NTIA and FDA

The Partnership for Safe Medicines (PSM) applauds the Food and Drug Administration (FDA) and the National Telecommunications and Information Administration (NTIA) pilot program established this week to curb unapproved opioids illegally available online by potentially suspending or blocking offending domain names.

[...]

Criminal Internet Pharmacy Networks Are Capitalizing on COVID-19.

In May 2020, the National Association of Boards of Pharmacy (NABP) released Rogue Online Pharmacies in the Time of Pandemic: Capitalizing on Misinformation and Fear, which focuses on how established fake pharmacy networks have pivoted to cash in on the coronavirus. PSM’s illustrated version of the report offers a compact summary of NABP’s work. Watch…

[...]

Policy Resolution on Counterfeit Device Destruction, May 8, 2020

The following policy resolution was passed unanimously at the May 8, 2020 Advisory Board meeting: The Partnership for Safe Medicines believes that counterfeit medical devices are dangerous to American patients and that the U.S. Food and Drug Administration (FDA) should have the unequivocal power to seize and destroy these dangerous products whether they are found…

[...]

How Many Tests Need to Be Performed to Know That a Batch of Pills is Safe?

Testing medicine for legitimacy is a complicated process. Across 24 different prescription medicines, the average cost to test a single dose is $2,750. However, ensuring that a batch of 100 pills is 90% certain to be safe requires testing at least 22 pills. Achieving 99.999% certainty requires even more testing, at tremendous expense. To learn more about this topic, read PSM’s summary: safedr.ug/Acri-Explained.

[...]

HHS comments come in overwhelmingly against Canadian drug importation proposal

Yesterday ended a 78-day comment period for the White House’s proposal to import medicine from Canada. In all, over 1,000 comments were filed. Overwhelmingly, these comments opposed the proposed rule or expressed skepticism that the rule could meet the two requirements listed in the Medicare Modernization Act of 2003: be safe and save consumers money. In fact, when you read the comments, it is clear that this policy is overwhelming opposed by experts on the issues of economics and medicine safety.

[...]

Canadian Importation Does Not Work

graph comparing the population of Canada to the US

The number of U.S. residents in states that are considering importing drugs from Canada is almost four times Canada’s own population. Canadian drug importation is not the structural solution we need.

[...]